跳到主要內容

簡易檢索 / 詳目顯示

回結果列表
研究生： 林揚芷
Yang-Chih Lin
論文名稱： 揭示CEP55基因在大腸直腸癌轉移中所扮演的角色
Clarifying role of CEP55 in colorectal cancer metastasis
指導教授： 蘇立仁
Li-Jen Su
口試委員:
學位類別： 碩士
Master
系所名稱： 生醫理工學院 - 系統生物與生物資訊研究所
Graduate Institute of Systems Biology and Bioinformatics
論文出版年： 2015
畢業學年度： 103
語文別： 英文
論文頁數： 85
中文關鍵詞： 大腸直腸癌 、轉移 、CEP55 、高通量定序技術
外文關鍵詞： Colorectal cancer, metastasis, CEP55, high-throughput mRNA sequencing
相關次數： 點閱：14  下載：0 
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報

    • 大腸直腸癌好發率高居世界第三，且轉移性大腸直腸癌會使治療更加困難。本研究討論CEP55在大腸直腸癌扮演的角色，以釐清轉移性大腸直腸癌的機制。CEP55是一個轉錄中心體蛋白，在細胞增生上扮演重要角色，且已被發現在肝癌、肺癌、頭頸癌和鼻咽癌中過度表現。此研究包含三個部分，第一個部分是利用四個獨立公開的數據組來比較大腸直腸癌患者與健康族群的CEP55的表現量。第二部分是利用免疫組織染色程度來評估110例大腸直腸癌的CEP55表現量和淋巴結擴散程度的相關性。第三部分，藉由質體轉染及小分子干擾核糖核酸來改變HCT116細胞中CEP55的表現程度，再利用高通量信息RNA定序來得到CEP55的完整調控資訊。結果顯示，CEP55在大腸直腸癌的表現量升高。且CEP55的表現量與淋巴結擴散程度呈正相關性。最後結果顯示CEP55能促進細胞的爬行，並利用高通量定序技術，揭示跟CEP55共同調控的基因、功能及路徑。以上的整體結果能幫助深入了解轉移性大腸直腸癌的分子機制，也示意CEP55可能做為治療轉移性大腸直腸癌的標靶。

    Colorectal cancer (CRC) has the third highest incidence rate among all cancers worldwide and becomes radically more difficult to treat when it is metastatic. Here, to provide insight into the mechanisms underlying CRC metastasis, we describe the role in CRC metastasis of CEP55, which is the encoding gene of a centrosomal protein essential to proliferation and has been reported to be overexpressed in hepatocellular carcinoma, lung cancer, head and neck cancer and nasopharyngeal carcinomas. The study comprises three steps. The first step was to measure the relative expression levels of CEP55 in CRC patients compared with healthy controls, using four independent public datasets. The second step was to assess correlation between metastasis and CEP55 expression level, using 110 staged CRCs and their Immunohistochemistry-based grades. The third step was to artificially alter CEP55 expression levels in HCT116 cells, using plasmid-implanted CEP55 clones and siRNA knockdowns, and to apply high-throughput mRNA sequencing to holistically profile the resultant co-regulation information. The results show elevated CEP55 levels in CRCs over controls. And the results reveal positive correlation between CEP55 level and spreading status to lymph nodes. CEP55 promotes cell migration and delineates the involved genes, functions and pathways in CEP55 co-regulation. The results overall pave the way for deeper understandings of the underlying molecular mechanisms and suggest CEP55 as a therapeutic target for CRC metastasis.

    中文摘要 i Abstract ii 誌謝 iii Table of contents iii List of tables vi List of figures vii List of supplements tables viii List of supplements figures ix 1. Introduction 1 1-1. Colorectal cancer 1 1-2. CRC metastasis 2 1-3. Role of centrosomal protein CEP55 3 2. Materials and methods 5 2-1. Public data collection 5 2-2. CRC tissue preparation 5 2-3. Cell culture conditions 5 2-4. Cell transient transfections and stabilization 6 2-5. Immunohistochemical staining (IHC) 6 2-6. RNA extraction 7 2-7. Protein extraction 8 2-8. RT-PCR 9 2-9. Western blot assay 10 2-10. Wound-healing assay 10 2-11. Cell migration assay 11 2-12. RNA-seq library construction and sequencing 11 2-3-2. RNA-seq data analysis 12 3. Results 14 3-1. Transcriptome analysis 14 3-2. Clinicopathological analysis 20 3-3. Cytological analysis 23 3-3-1. Promotion of CRC migration by CEP55 23 3-3-2. RNA-seq data analysis 28 3-3-3. Differential gene expression and bioinformatics analysis 30 3-3-4. CEP55 co-expression analysis 35 4. Discussion 43 5. Reference 46 6. Supplements 48

    1. Health Promotion Administration, Ministry of Health and Welfare, Tiawan
    2013.
    2. American Cancer Society (ACS). http://www.cancer.org/index, 1913.
    3. Abajo, A., et al., Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array. World journal of gastroenterology: WJG, 2012. 18(7): p. 637.
    4. de Krijger, I., et al., MicroRNAs in colorectal cancer metastasis. The Journal of pathology, 2011. 224(4): p. 438-447.
    5. Hunter, K.W., N. Crawford, and J. Alsarraj, Mechanisms of metastasis. Breast Cancer Res, 2008. 10(Suppl 1): p. S2.
    6. Liu, L., et al., microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochemical and biophysical research communications, 2010. 400(2): p. 236-240.
    7. Kheirelseid, E.A., N. Miller, and M.J. Kerin, Molecular biology of colorectal cancer: Review of the literature. 2013.
    8. Fabbro, M., et al., Cdk1/Erk2-and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis. Developmental cell, 2005. 9(4): p. 477-488.
    9. Sakai, M., et al., Elevated expression of C10orf3 (chromosome 10 open reading frame 3) is involved in the growth of human colon tumor. Oncogene, 2006. 25(3): p. 480-486.
    10. Zhao, W.-m., A. Seki, and G. Fang, Cep55, a microtubule-bundling protein, associates with centralspindlin to control the midbody integrity and cell abscission during cytokinesis. Molecular biology of the cell, 2006. 17(9): p. 3881-3896.
    11. Trapnell, C., et al., Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nature protocols, 2012. 7(3): p. 562-578.
    12. Huang, D.W., B.T. Sherman, and R.A. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols, 2008. 4(1): p. 44-57.
    13. Huang, D.W., B.T. Sherman, and R.A. Lempicki, Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic acids research, 2009. 37(1): p. 1-13.
    14. Duan, Q., et al., LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures. Nucleic acids research, 2014: p. gku476.
    15. Hanahan, D. and R.A. Weinberg, The hallmarks of cancer. cell, 2000. 100(1): p. 57-70.
    16. Zucker, S. and J. Vacirca, Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer and Metastasis Reviews, 2004. 23(1-2): p. 101-117.
    17. Adachi, Y., et al., Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut, 1999. 45(2): p. 252-258.
    18. Jakowlew, S.B., Transforming growth factor-β in cancer and metastasis. Cancer and Metastasis Reviews, 2006. 25(3): p. 435-457.
    19. Loboda, A., et al., EMT is the dominant program in human colon cancer. BMC medical genomics, 2011. 4(1): p. 9.
    20. Conacci-Sorrell, M., et al., Stress-induced cleavage of Myc promotes cancer cell survival. Genes & development, 2014. 28(7): p. 689-707.
    21. Stewart, S. and G. Fang, Anaphase-promoting complex/cyclosome controls the stability of TPX2 during mitotic exit. Molecular and cellular biology, 2005. 25(23): p. 10516-10527.
    22. Wei, P., et al., TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer. J Transl Med, 2013. 11: p. 313.
    23. Chen, C., et al., FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway. Oncogene, 2007. 26(29): p. 4272-4283.
    24. Chen, C.-H., et al., Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer. Molecular cancer, 2015. 14(1): p. 83.
    25. Chen, C.-H., et al., VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3K/AKT pathway. PloS one, 2009. 4(4): p. e5052.
    26. Chen, C.-H., et al., FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway. J Transl Med, 2012. 10(93): p. 10.1186.
    27. AJCC, Colon and Rectum Cancer Staging - American Joint Committee on Cancer (AJCC).

    QR CODE
    :::